Skip to Main Content

WASHINGTON — Newly disclosed financial records show that President Trump’s nominee to become Health and Human Services secretary reaped big earnings during his tenure as a top pharmaceutical executive.

As a top drug industry veteran from 2007 to 2017, former Eli Lilly and Co. executive Alex Azar built a substantial financial portfolio now worth $9.5 million to $20.6 million, and he was paid nearly $2 million in his final year at the company.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED